McGettrick, P;
Mallon, PW;
Sabin, CA;
(2020)
Cardiovascular disease in HIV patients: recent advances in predicting and managing risk.
Expert Review of Anti-infective Therapy
, 18
(7)
pp. 677-688.
10.1080/14787210.2020.1757430.
Preview |
Text
Cardiovascular disease in HIV patients recent advances in predicting and managing risk.pdf - Accepted Version Download (809kB) | Preview |
Abstract
Introduction: Cardiovascular disease (CVD) is one of the leading causes of mortality in virally suppressed people living with HIV (PLWH) and with an ageing population, is likely to become one of the leading challenges in maintaining good health outcomes in HIV infection. However, factors driving risk of CVD in PLWH are multiple and may be different from those of the general population, raising challenges to predicting and managing CVD risk in this population. / Areas covered: In this review, we examine the relevant data regarding CVD in HIV infection including that on CVD prevalence, pathogenesis and contributing factors. We review the data regarding CVD risk prediction in PLWH and summarise factors, both general and HIV specific, that may influence CVD risk in this population. And finally we discuss appropriate management of CVD risk in PLWH and explore potential therapeutic pathways which may mitigate CVD risk in the future in this population. / Expert opinion: Following a comprehensive review of CVD risk in PLWH, we give our opinion on the primary issues in risk prediction and management of CVD in HIV infected individuals and discuss the future direction of CVD management in this population.
Archive Staff Only
 |
View Item |
